Latest stories on SVRA
Savara announces presentations of Results from Phase 3 trial of Molgramostim
The Fly63 · neutralproduct/pr
Savara Announces New Employment Inducement Grant
StockTitan50 · neutralgeneral
Savara GAAP EPS of -$0.16 misses by $0.02
Seeking Alpha34 · bearishearnings
Savara reports Q2 EPS (16c), consensus (15c)
The Fly51 · neutralearnings
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan55 · neutralearnings
Savara: High Potential Binary Bet Cruising To PDUFA After 3 Month Speed Bump
Seeking Alpha63 · neutralproduct/pr
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline
The Motley Fool42 · neutralgeneral
Savara Announces New Employment Inducement Grant | SVRA Stock News
StockTitan50 · neutralgeneral
Savara Expands Share Capital and Updates Executive Leadership
TipRanks42 · neutralgeneral
Savara CFO to step down
Seeking Alpha42 · neutralgeneral
Savara Inc (SVRA) files 8-K
SEC 8-K50 · neutralgeneral
Savara Announces Chief Financial and Administrative Officer Transition | SVRA Stock News
StockTitan50 · neutralgeneral
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference | SVRA Stock News
StockTitan55 · neutralgeneral
Savara: The Rare Disease Funnel Is Becoming A Commercial Asset
Seeking Alpha63 · neutralproduct/pr
Savara Inc. (SVRA) Reports Q1 Financial Results
Yahoo Top48 · neutralearnings